Industry Looks To Califf’s Leadership As It Negotiates User Fee Deal, Fights Pandemic
Executive Summary
After the US Senate barely greenlit Robert Califf to again helm the US FDA, industry sources say they look forward to him taking an active role in ensuring the next user fee deal is successful.